Kim, S.; Lee, Y.; Song, B.R.; Sim, H.; Kang, E.H.; Hwang, M.; Yu, N.; Hong, S.; Park, C.; Ahn, B.-C.;
et al. Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy. Cancers 2024, 16, 778.
https://doi.org/10.3390/cancers16040778
AMA Style
Kim S, Lee Y, Song BR, Sim H, Kang EH, Hwang M, Yu N, Hong S, Park C, Ahn B-C,
et al. Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy. Cancers. 2024; 16(4):778.
https://doi.org/10.3390/cancers16040778
Chicago/Turabian Style
Kim, Sunshin, Youngjoo Lee, Bo Ram Song, Hanna Sim, Eun Hye Kang, Mihwa Hwang, Namhee Yu, Sehwa Hong, Charny Park, Beung-Chul Ahn,
and et al. 2024. "Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy" Cancers 16, no. 4: 778.
https://doi.org/10.3390/cancers16040778
APA Style
Kim, S., Lee, Y., Song, B. R., Sim, H., Kang, E. H., Hwang, M., Yu, N., Hong, S., Park, C., Ahn, B.-C., Lim, E. J., Hwang, K. H., Park, S.-Y., Choi, J.-H., Lee, G. K., & Han, J.-Y.
(2024). Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy. Cancers, 16(4), 778.
https://doi.org/10.3390/cancers16040778